Wiilbur
Interesting news you bring.
However, your statement that a C broker is being used this time "to try to get some fresh blood" throws me somewhat. What does that mean?
The only fresh blood I want is from a cornerstone investor, not just people like us and sophs, except OS ones. Your said words suggest to me though that this is just perhaps a one-off deal (ie to raise $ to pay the CBs),and nothing more, and that the money is coming via a C broker through its clients. That does not excite me at all to be honest.
However, if those words mean that the C broker has a cornerstone investor in tow, then that pleases me. That WOULD BE "new blood". But your words about "try to get" suggest otherwise to me. All we'll have if that is the case will be new s'holders like us, except they will be from OS. How does that improve our situation?
Any comment on that from your source W would be appreciated W, but really I'm now prepared to wait now til the ann comes out to find out what the facts are. No more speculation from me.
Thanks for the information though. A good post.
- Forums
- ASX - By Stock
- PEK
- is this the answer
is this the answer, page-23
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEK (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.28M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.0¢ | $28.85K | 157.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19986 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 21488 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19991 | 0.180 |
7 | 549624 | 0.175 |
5 | 833674 | 0.170 |
4 | 282886 | 0.165 |
5 | 268156 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 21488 | 2 |
0.195 | 71880 | 2 |
0.200 | 11255 | 2 |
0.210 | 66000 | 2 |
0.215 | 10807 | 2 |
Last trade - 15.11pm 15/07/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online